Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 631

1.

Dried blood microsampling-based therapeutic drug monitoring of anti-epileptic drugs in children with nodding syndrome and epilepsy in Uganda and the Democratic Republic of the Congo.

Velghe S, Delahaye L, Ogwang R, Hotterbeekx A, Colebunders R, Mandro M, Idro R, Stove CP.

Ther Drug Monit. 2019 Dec 9. doi: 10.1097/FTD.0000000000000720. [Epub ahead of print]

PMID:
31834012
2.

Epilepsy prevention.

Fodjo JNS, Makoy YL, Colebunders R.

Lancet. 2019 Dec 7;394(10214):2072. doi: 10.1016/S0140-6736(19)31906-3. No abstract available.

PMID:
31818410
3.

Nodding syndrome research, lessons learned from the NSETHIO project.

Geelhand de Merxem D, Siewe Fodjo JN, Menon S, Hotterbeekx A, Colebunders R.

Glob Ment Health (Camb). 2019 Oct 18;6:e26. doi: 10.1017/gmh.2019.24. eCollection 2019. Review.

4.

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy.

Hotterbeekx A, Raimon S, Abd-Elfarag G, Y Carter J, Sebit W, Suliman A, Nelson Siewe Fodjo J, De Witte P, Yibi Logora M, Colebunders R, Kumar-Singh S.

Int J Infect Dis. 2019 Nov 28. pii: S1201-9712(19)30469-2. doi: 10.1016/j.ijid.2019.11.029. [Epub ahead of print]

5.

Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programs.

Colebunders R, Wafula ST, Hotterbeekx A, Siewe-Fodjo JN.

Br J Dermatol. 2019 Nov 6. doi: 10.1111/bjd.18685. [Epub ahead of print]

PMID:
31693749
6.

Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania.

Bhwana D, Mmbando BP, Dekker MC, Mnacho M, Kakorozya A, Matuja W, Makunde WH, Weckhuysen S, Colebunders R.

Epileptic Disord. 2019 Oct 1;21(5):425-435. doi: 10.1684/epd.2019.1093.

PMID:
31649005
7.

Nodding Syndrome: Close to Solving the Mystery.

Bhwana D, Mmbando B, Hotterbeekx A, Colebunders R.

Pediatr Infect Dis J. 2019 Nov;38(11):e313. doi: 10.1097/INF.0000000000002442. No abstract available.

PMID:
31626053
8.

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.

Colebunders R, Stolk WA, Siewe Fodjo JN, Mackenzie CD, Hopkins A.

Infect Dis Poverty. 2019 Oct 3;8(1):83. doi: 10.1186/s40249-019-0593-x.

9.

Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome.

Hotterbeekx A, Lammens M, Idro R, Akun PR, Lukande R, Akena G, Nath A, Taylor J, Olwa F, Kumar-Singh S, Colebunders R.

J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1049-1058. doi: 10.1093/jnen/nlz090.

10.

Analysis of the RIMDAMAL trial.

Colebunders R, Kugler M, Fodjo JNS.

Lancet. 2019 Sep 21;394(10203):1006. doi: 10.1016/S0140-6736(19)31814-8. No abstract available.

PMID:
31544741
11.

Emergomyces: The global rise of new dimorphic fungal pathogens.

Schwartz IS, Govender NP, Sigler L, Jiang Y, Maphanga TG, Toplis B, Botha A, Dukik K, Hoving JC, Muñoz JF, de Hoog S, Cuomo CA, Colebunders R, Kenyon C.

PLoS Pathog. 2019 Sep 19;15(9):e1007977. doi: 10.1371/journal.ppat.1007977. eCollection 2019 Sep. No abstract available.

12.

Women with epilepsy in sub-Saharan Africa: A review of the reproductive health challenges and perspectives for management.

Menon S, Siewe Fodjo JN, Weckhuysen S, Bhwana D, Njamnshi AK, Dekker M, Colebunders R.

Seizure. 2019 Oct;71:312-317. doi: 10.1016/j.seizure.2019.08.016. Epub 2019 Sep 6. Review.

13.

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?

Siewe Fodjo JN, Kugler M, Hotterbeekx A, Hendy A, Van Geertruyden JP, Colebunders R.

Infect Dis Poverty. 2019 Aug 23;8(1):77. doi: 10.1186/s40249-019-0588-7.

14.

The efficacy of a brief intervention to reduce alcohol use in persons with HIV in South Africa, a randomized clinical trial.

Huis In 't Veld D, Ensoy-Musoro C, Pengpid S, Peltzer K, Colebunders R.

PLoS One. 2019 Aug 20;14(8):e0220799. doi: 10.1371/journal.pone.0220799. eCollection 2019.

15.

Increased cost-benefit of strengthening onchocerciasis elimination efforts in areas with high onchocerciasis-associated epilepsy.

Colebunders R, Raimon S, Siewe Fodjo JN, Carter JY.

Trop Med Int Health. 2019 Oct;24(10):1259. doi: 10.1111/tmi.13300. Epub 2019 Aug 21. No abstract available.

PMID:
31393635
16.

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

Colebunders R, Siewe Fodjo JN, Hopkins A, Hotterbeekx A, Lakwo TL, Kalinga A, Logora MY, Basáñez MG.

PLoS Negl Trop Dis. 2019 Jul 18;13(7):e0007407. doi: 10.1371/journal.pntd.0007407. eCollection 2019 Jul. No abstract available.

17.

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.

Siewe Fodjo JN, Mandro M, Mukendi D, Tepage F, Menon S, Nakato S, Nyisi F, Abhafule G, Wonya'rossi D, Anyolito A, Lokonda R, Hotterbeekx A, Colebunders R.

PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300. doi: 10.1371/journal.pntd.0007300. eCollection 2019 Jul.

18.

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa.

Siewe Fodjo JN, Mubiru F, Ukaga C, Logora MY, Mmbando BP, Mandro M, Njamnshi AK, Colebunders R.

Int Health. 2019 Jun 28. pii: ihz044. doi: 10.1093/inthealth/ihz044. [Epub ahead of print]

PMID:
31251354
19.

Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo.

Siewe Fodjo JN, Mandro M, Wonya'rossi D, Inaç Y, Ngave F, Lokonda R, Anyolito A, Verelst F, Colebunders R.

EClinicalMedicine. 2019 Mar 27;9:60-66. doi: 10.1016/j.eclinm.2019.03.010. eCollection 2019 Mar.

20.

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania.

Kaiser C, Mmbando BP, Siewe Fodjo JN, Suykerbuyk P, Mnacho M, Kakorozya A, Matuja W, Hendy A, Greter H, Makunde WH, Colebunders R.

Infect Dis Poverty. 2019 May 24;8(1):35. doi: 10.1186/s40249-019-0545-5.

21.

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group.

O'Neill S, Irani J, Siewe Fodjo JN, Nono D, Abbo C, Sato Y, Mugarura A, Dolo H, Ronse M, Njamnshi AK, Colebunders R.

Infect Dis Poverty. 2019 May 20;8(1):34. doi: 10.1186/s40249-019-0544-6. Review.

22.

Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.

Goovaerts O, Massinga-Loembé M, Ondoa P, Ceulemans A, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L; TB-IRIS Study Group.

PLoS One. 2019 Apr 25;14(4):e0215991. doi: 10.1371/journal.pone.0215991. eCollection 2019.

23.

New filovirus disease classification and nomenclature.

Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z.

Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. No abstract available.

24.

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.

Boullé C, Njamnshi AK, Dema F, Mengnjo MK, Siewe Fodjo JN, Bissek AZ, Suykerbuyk P, Lenou-Nanga CG, Nana-Djeunga HC, Kamgno J, Chesnais CB, Boussinesq M, Colebunders R.

Parasit Vectors. 2019 Mar 19;12(1):114. doi: 10.1186/s13071-019-3345-7.

25.

Epidemiological evidence concerning the association between onchocerciasis and epilepsy.

Siewe Fodjo JN, Tepage F, Colebunders R.

Int J Infect Dis. 2019 May;82:77-78. doi: 10.1016/j.ijid.2019.03.015. Epub 2019 Mar 15. No abstract available.

26.

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys.

Siewe Fodjo JN, Dekker MCJ, Idro R, Mandro MN, Preux PM, Njamnshi AK, Colebunders R.

Infect Dis Poverty. 2019 Feb 10;8(1):11. doi: 10.1186/s40249-019-0523-y. Review.

27.

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.

Mukendi D, Tepage F, Akonda I, Siewe JNF, Rotsaert A, Ndibmun CN, Laudisoit A, Couvreur S, Kabutako B, Menon S, Hotterbeekx A, Colebunders R.

Int J Infect Dis. 2019 Feb;79:187-194. doi: 10.1016/j.ijid.2018.10.021.

28.

Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.

Dolo H, Coulibaly YI, Dembele B, Guindo B, Coulibaly SY, Dicko I, Doumbia SS, Dembele M, Traore MO, Goita S, Dolo M, Soumaoro L, Coulibaly ME, Diallo AA, Diarra D, Zhang Y, Colebunders R, Nutman TB.

PLoS Negl Trop Dis. 2019 Jan 30;13(1):e0007064. doi: 10.1371/journal.pntd.0007064. eCollection 2019 Jan.

29.

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.

Siewe JNF, Ukaga CN, Nwazor EO, Nwoke MO, Nwokeji MC, Onuoha BC, Nwanjor SO, Okeke J, Osahor K, Chimechefulam L, Ogomaka AI, Amaechi AA, Ezenwa CI, Ezike MN, Ikpeama C, Nwachukwu O, Eriama-Joseph AI, Nwoke BEB, Colebunders R.

Infect Dis Poverty. 2019 Jan 23;8(1):8. doi: 10.1186/s40249-019-0517-9.

30.

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.

Siewe Fodjo JN, Tatah G, Tabah EN, Ngarka L, Nfor LN, Chokote SE, Mengnjo MK, Dema F, Sitouok AT, Nkoro G, Ntone FE, Bissek AZ, Chesnais CB, Boussinesq M, Colebunders R, Njamnshi AK.

Infect Dis Poverty. 2018 Dec 3;7(1):114. doi: 10.1186/s40249-018-0497-1.

31.

Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon.

Siewe JFN, Ngarka L, Tatah G, Mengnjo MK, Nfor LN, Chokote ES, Boullé C, Nkouonlack C, Dema F, Nkoro GA, Njamnshi WY, Tabah EN, Zoung-Kanyi Bissek AC, Colebunders R, Njamnshi AK.

Epilepsy Behav. 2019 Jan;90:70-78. doi: 10.1016/j.yebeh.2018.11.008. Epub 2018 Dec 1.

PMID:
30513438
32.

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo.

Dolo H, Mandro M, Wonya'Rossi D, Ngave F, Fraeyman J, Siewe JN, Suykerbuyk P, Colebunders R.

Infect Dis Poverty. 2018 Dec 4;7(1):115. doi: 10.1186/s40249-018-0498-0.

33.

High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.

Colebunders R, Y Carter J, Olore PC, Puok K, Bhattacharyya S, Menon S, Abd-Elfarag G, Ojok M, Ensoy-Musoro C, Lako R, Logora MY.

Seizure. 2018 Dec;63:93-101. doi: 10.1016/j.seizure.2018.11.004. Epub 2018 Nov 13.

34.

Oral Tecovirimat for the Treatment of Smallpox.

Laudisoit A, Tepage F, Colebunders R.

N Engl J Med. 2018 Nov 22;379(21):2084-2085. doi: 10.1056/NEJMc1811044. No abstract available.

PMID:
30462945
35.

Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.

Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, Ravinetto R, van Loen H, Nair A, Jackson A, Colebunders R, Maartens G, Wilkinson RJ, Lynen L; PredART Trial Team.

N Engl J Med. 2018 Nov 15;379(20):1915-1925. doi: 10.1056/NEJMoa1800762.

36.

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.

Abd-Elfarag G, Logora MY, Carter JY, Ojok M, Songok J, Menon S, Wit F, Lako R, Colebunders R.

Infect Dis Poverty. 2018 Nov 14;7(1):112. doi: 10.1186/s40249-018-0496-2.

37.

Factors Influencing the Risk of Becoming Sexually Active Among HIV Infected Adolescents in Kampala and Kisumu, East Africa.

Bakeera-Kitaka S, Smekens T, Jespers V, Wobudeya E, Loos J, Colebunders R, Adipo D, Kekitiinwa A, Musoke P, Buve A, Nöstlinger C.

AIDS Behav. 2019 Jun;23(6):1375-1386. doi: 10.1007/s10461-018-2323-y.

PMID:
30406334
38.

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Burnett SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, Colebunders R, Manabe YC.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):605-611. doi: 10.1097/QAI.0000000000001862.

39.

Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan.

Colebunders R, Abd-Elfarag G, Carter JY, Olore PC, Puok K, Menon S, Fodjo Siewe JN, Bhattacharyya S, Ojok M, Lako R, Logora MY.

Seizure. 2018 Nov;62:108-115. doi: 10.1016/j.seizure.2018.10.004. Epub 2018 Oct 5.

40.

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.

Mandro M, Suykerbuyk P, Tepage F, Rossy D, Ngave F, Hasan MN, Hotterbeekx A, Mambandu G, Kashama JM, Laudisoit A, Colebunders R.

Infect Dis Poverty. 2018 Oct 8;7(1):79. doi: 10.1186/s40249-018-0465-9.

41.

The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.

Chesnais CB, Nana-Djeunga HC, Njamnshi AK, Lenou-Nanga CG, Boullé C, Bissek AZ, Kamgno J, Colebunders R, Boussinesq M.

Lancet Infect Dis. 2018 Nov;18(11):1278-1286. doi: 10.1016/S1473-3099(18)30425-0. Epub 2018 Sep 26.

PMID:
30268645
42.

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities.

Vinkeles Melchers NVS, Mollenkopf S, Colebunders R, Edlinger M, Coffeng LE, Irani J, Zola T, Siewe JN, de Vlas SJ, Winkler AS, Stolk WA.

Infect Dis Poverty. 2018 Sep 19;7(1):101. doi: 10.1186/s40249-018-0481-9. Review.

43.

Is nodding syndrome in northern Uganda linked to consumption of mycotoxin contaminated food grains?

Echodu R, Edema H, Malinga GM, Hendy A, Colebunders R, Moriku Kaducu J, Ovuga E, Haesaert G.

BMC Res Notes. 2018 Sep 24;11(1):678. doi: 10.1186/s13104-018-3774-y.

44.

Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS).

Goovaerts O, Mwinzi PNM, Muok EMO, Ceulemans A, Colebunders R, Kestens L.

PLoS Negl Trop Dis. 2018 Aug 8;12(8):e0006710. doi: 10.1371/journal.pntd.0006710. eCollection 2018 Aug.

45.

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.

Lenaerts E, Mandro M, Mukendi D, Suykerbuyk P, Dolo H, Wonya'Rossi D, Ngave F, Ensoy-Musoro C, Laudisoit A, Hotterbeekx A, Colebunders R.

Infect Dis Poverty. 2018 Aug 1;7(1):68. doi: 10.1186/s40249-018-0452-1.

46.

Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.

Worodria W, Ssempijja V, Hanrahan C, Ssegonja R, Muhofwa A, Mazapkwe D, Mayanja-Kizza H, Reynolds SJ, Colebunders R, Manabe YC.

AIDS. 2018 Sep 24;32(15):2141-2149. doi: 10.1097/QAD.0000000000001941.

47.

Histological examination of post-mortem brains of children with nodding syndrome.

Hotterbeekx A, Onzivua S, Menon S, Colebunders R.

Ann Transl Med. 2018 Apr;6(7):134. doi: 10.21037/atm.2018.02.04. No abstract available.

48.

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.

Mmbando BP, Suykerbuyk P, Mnacho M, Kakorozya A, Matuja W, Hendy A, Greter H, Makunde WH, Colebunders R.

Infect Dis Poverty. 2018 Jun 20;7(1):64. doi: 10.1186/s40249-018-0450-3.

49.

Factors Associated with Wuchereria bancrofti Microfilaremia in an Endemic Area of Mali.

Dolo H, Coulibaly YI, Kelly-Hope L, Konate S, Dembele B, Coulibaly SY, Sanogo D, Soumaoro L, Coulibaly ME, Doumbia SS, Diallo AA, Traore SF, Colebunders R, Nutman TB, Klion AD.

Am J Trop Med Hyg. 2018 Jun;98(6):1782-1787. doi: 10.4269/ajtmh.17-0902. Epub 2018 Apr 26.

50.

Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.

Greter H, Mmbando B, Makunde W, Mnacho M, Matuja W, Kakorozya A, Suykerbuyk P, Colebunders R.

BMJ Open. 2018 Mar 31;8(3):e017188. doi: 10.1136/bmjopen-2017-017188.

Supplemental Content

Loading ...
Support Center